Clinical Trial Update: Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating intranasal sphenopalatine ganglion blockade for headaches following aneurysmal subarachnoid hemorrhage; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Headache

Drugs mentioned

• Intranasal Sphenopalatine Ganglion Blockade (Sphenopalatine ganglion blockade, intranasal)

Snippet

Sponsor: Wright State University | Conditions: Aneurysmal Subarachnoid Hemorrhage (aSAH), Headache | Phase 4 | Status: RECRUITING